bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium)

C137H274N20OV2-2 — CID 162121494

IUPACbis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium)
SMILESCC(C)(C)C1CC(=O)N(C2CCN(C(C)(C)C)CC2)C1.CC(C)(C)C1CCN(C2CCN(C(C)(C)C)CC2)C1.CC(C)(C)N1CCC(C2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)N1CCC(N2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)N1CCC(N2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)N1CCC([N-]C2CCN(C(C)(C)C)C2)CC1.CC(C)(C)N1CCC([N-]C2CCN(C(C)(C)C)C2)CC1.CC(C)(C)N1CCC2(CC1)CCN(C(C)(C)C)CC2.[V].[V]
InChIInChI=1S/C18H36N2.2C17H34N3.2C17H35N3.C17H32N2O.2C17H34N2.2V/c1-17(2,3)19-11-7-15(8-12-19)16-9-13-20(14-10-16)18(4,5)6;2*1-16(2,3)19-10-7-14(8-11-19)18-15-9-12-20(13-15)17(4,5)6;2*1-16(2,3)19-9-7-15(8-10-19)18-11-13-20(14-12-18)17(4,5)6;1-16(2,3)13-11-15(20)19(12-13)14-7-9-18(10-8-14)17(4,5)6;1-15(2,3)18-11-7-17(8-12-18)9-13-19(14-10-17)16(4,5)6;1-16(2,3)14-7-10-18(13-14)15-8-11-19(12-9-15)17(4,5)6;;/h15-16H,7-14H2,1-6H3;2*14-15H,7-13H2,1-6H3;2*15H,7-14H2,1-6H3;13-14H,7-12H2,1-6H3;7-14H2,1-6H3;14-15H,7-13H2,1-6H3;;/q;2*-1;;;;;;;
InChIKeyWKUJZPQZJCMTJK-UHFFFAOYSA-N
MW2319.73 g/mol
LogP26.85
Rot. Bonds9

About bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium)

bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium) (PubChem CID 162121494) has the molecular formula C137H274N20OV2-2 and a molecular weight of 2319.73 g/mol. Its IUPAC name is bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium).

Molecular Properties

Compound Namebis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium)
PubChem CID162121494
Molecular FormulaC137H274N20OV2-2
Molecular Weight2319.73 g/mol
Exact Mass2318.09
IUPAC Namebis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium)
SMILESCC(C)(C)C1CC(=O)N(C2CCN(C(C)(C)C)CC2)C1.CC(C)(C)C1CCN(C2CCN(C(C)(C)C)CC2)C1.CC(C)(C)N1CCC(C2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)N1CCC(N2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)N1CCC(N2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)N1CCC([N-]C2CCN(C(C)(C)C)C2)CC1.CC(C)(C)N1CCC([N-]C2CCN(C(C)(C)C)C2)CC1.CC(C)(C)N1CCC2(CC1)CCN(C(C)(C)C)CC2.[V].[V]
InChIInChI=1S/C18H36N2.2C17H34N3.2C17H35N3.C17H32N2O.2C17H34N2.2V/c1-17(2,3)19-11-7-15(8-12-19)16-9-13-20(14-10-16)18(4,5)6;2*1-16(2,3)19-10-7-14(8-11-19)18-15-9-12-20(13-15)17(4,5)6;2*1-16(2,3)19-9-7-15(8-10-19)18-11-13-20(14-12-18)17(4,5)6;1-16(2,3)13-11-15(20)19(12-13)14-7-9-18(10-8-14)17(4,5)6;1-15(2,3)18-11-7-17(8-12-18)9-13-19(14-10-17)16(4,5)6;1-16(2,3)14-7-10-18(13-14)15-8-11-19(12-9-15)17(4,5)6;;/h15-16H,7-14H2,1-6H3;2*14-15H,7-13H2,1-6H3;2*15H,7-14H2,1-6H3;13-14H,7-12H2,1-6H3;7-14H2,1-6H3;14-15H,7-13H2,1-6H3;;/q;2*-1;;;;;;;
InChIKeyWKUJZPQZJCMTJK-UHFFFAOYSA-N
XLogP26.85
TPSA103.59 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds9
Heavy Atoms160
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002319.73
LogP ≤ 526.85
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Analyze bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium)?
The IUPAC name of bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium) (CID 162121494) is bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium).
What is the SMILES notation for bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium)?
The canonical SMILES for bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium) is CC(C)(C)C1CC(=O)N(C2CCN(C(C)(C)C)CC2)C1.CC(C)(C)C1CCN(C2CCN(C(C)(C)C)CC2)C1.CC(C)(C)N1CCC(C2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)N1CCC(N2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)N1CCC(N2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)N1CCC([N-]C2CCN(C(C)(C)C)C2)CC1.CC(C)(C)N1CCC([N-]C2CCN(C(C)(C)C)C2)CC1.CC(C)(C)N1CCC2(CC1)CCN(C(C)(C)C)CC2.[V].[V].
What is the InChIKey of bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium)?
The InChIKey is WKUJZPQZJCMTJK-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H36N2.2C17H34N3.2C17H35N3.C17H32N2O.2C17H34N2.2V/c1-17(2,3)19-11-7-15(8-12-19)16-9-13-20(14-10-16)18(4,5)6;2*1-16(2,3)19-10-7-14(8-11-19)18-15-9-12-20(13-15)17(4,5)6;2*1-16(2,3)19-9-7-15(8-10-19)18-11-13-20(14-12-18)17(4,5)6;1-16(2,3)13-11-15(20)19(12-13)14-7-9-18(10-8-14)17(4,5)6;1-15(2,3)18-11-7-17(8-12-18)9-13-19(14-10-17)16(4,5)6;1-16(2,3)14-7-10-18(13-14)15-8-11-19(12-9-15)17(4,5)6;;/h15-16H,7-14H2,1-6H3;2*14-15H,7-13H2,1-6H3;2*15H,7-14H2,1-6H3;13-14H,7-12H2,1-6H3;7-14H2,1-6H3;14-15H,7-13H2,1-6H3;;/q;2*-1;;;;;;;.
What are the key properties of bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium)?
bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium) has a molecular weight of 2319.73 g/mol, XLogP of 26.85, 9 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for bis(1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperazine);1-tert-butyl-4-(1-tert-butylpiperidin-4-yl)piperidine;4-tert-butyl-1-(1-tert-butylpiperidin-4-yl)pyrrolidin-2-one;1-tert-butyl-4-(3-tert-butylpyrrolidin-1-yl)piperidine;bis((1-tert-butylpiperidin-4-yl)-(1-tert-butylpyrrolidin-3-yl)azanide);3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;bis(vanadium) is sourced from PubChem (CID 162121494), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).